# Filing Detail

Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-135337
Filing Date
2024-05-09
Accepted
2024-05-09 16:50:31
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-3 | d823033ds3.htm | S-3 | 430872
2 | EX-1.2 | d823033dex12.htm | EX-1.2 | 190355
3 | EX-4.4 | d823033dex44.htm | EX-4.4 | 279128
4 | EX-5.1 | d823033dex51.htm | EX-5.1 | 16749
5 | EX-5.2 | d823033dex52.htm | EX-5.2 | 9992
6 | EX-23.1 | d823033dex231.htm | EX-23.1 | 1859
7 | EX-FILING FEES | d823033dexfilingfees.htm | EX-FILING FEES | 52770
8 | GRAPHIC | g823033g00a04.jpg | GRAPHIC | 605282
9 | GRAPHIC | g823033g00a40.jpg | GRAPHIC | 608065
10 | GRAPHIC | g823033g00a64.jpg | GRAPHIC | 37100
11 | GRAPHIC | g823033g0507073315005.jpg | GRAPHIC | 2668
| Complete submission text file | 0001193125-24-135337.txt |  | 2687356

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279275 | Film No.: 24931555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)